SCHEMBL28548926

SCHEMBL28548926

COc1ccc(O)c(C(=O)C(C)=O)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.58
ALDH1A1 P00352 5/20 0.58
CYP3A4 P08684 3/20 0.58
MAPK1 P28482 3/20 0.58
NPC1 O15118 4/20 0.55
RAB9A P51151 4/20 0.55
MEN1 O00255 5/20 0.53
KMT2A Q03164 5/20 0.53
MAPT P10636 5/20 0.53
KDM4E B2RXH2 4/20 0.53
SMN1; SMN2 Q16637 4/20 0.53
LMNA P02545 3/20 0.53
HSD17B10 Q99714 3/20 0.53
TP53 P04637 2/20 0.53
ALOX12 P18054 2/20 0.53
ALOX15 P16050 3/20 0.51
CYP1A2 P05177 2/20 0.51
PGR P06401 2/20 0.51
SLC6A2 P23975 2/20 0.51
CYP2C19 P33261 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29445806 0.85 ALDH1A1 (0.72) HPGDALDH1A1CYP3A4MAPK1NPC1
SCHEMBL312754 0.85 ALDH1A1 (0.72) HPGDALDH1A1CYP3A4MAPK1NPC1
SCHEMBL28093168 0.82 RAB9A (0.71) HPGDALDH1A1CYP3A4MAPK1NPC1
SCHEMBL28556103 0.81 MAPT (0.64) HPGDALDH1A1CYP3A4MAPK1NPC1
SCHEMBL6856233 0.81 NPC1 (0.58) HPGDALDH1A1CYP3A4MAPK1NPC1
SCHEMBL128781 0.81 CA1 (0.61) HPGDALDH1A1CYP3A4MAPK1NPC1
SCHEMBL29431885 0.81 CA1 (0.61) HPGDALDH1A1CYP3A4MAPK1NPC1
SCHEMBL2318688 0.80 TYK2 (0.52) HPGDALDH1A1CYP3A4MAPK1NPC1
SCHEMBL27864944 0.80 NPC1 (0.51) HPGDALDH1A1CYP3A4MAPK1NPC1
SCHEMBL3175654 0.79 NPC1 (0.56) HPGDALDH1A1CYP3A4MAPK1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112759510-A Preparation method of methoxamine hydrochloride degradation impurities 广东嘉博制药有限公司 2021-05-07 CN disclosed